
Sign up to save your podcasts
Or


Claims data suggest roughly one in three patients return after sinus surgery with persistent symptoms, and for many of them the complaint is drainage. On this episode of BackTable ENT & Allergy, host Dr. Ashley Agan welcomes Dr. Chris Davis, a comprehensive otolaryngologist in Birmingham, Alabama, whose practice is largely rhinology, to make the case that the persistent drainage after a technically perfect sinus surgery is a treatable problem rather than an acceptable residual. They discuss the anatomy and neuroimmune function of the posterior nasal nerve, how ablation may affect symptom scores and local inflammation, and the stepwise approach to patient selection and operative technique.
---
Get the BackTable app
https://www.backtable.com/app
---
This podcast is supported by
Aerin Medical
https://vivaer.com/
---
Timestamps
00:00 - Introduction
05:12 - CRS as a Chronic Disease and the Patient Still Draining
09:31 - Posterior Nasal Nerve Anatomy and Type 2 Inflammation
12:42 - Sensory Nerves, TRP Receptors and Neuroimmunomodulation
17:27 - Placebo Questions and Three-Year Durability
19:34 - Screening With TNSS, SNOT-22 and NOSE
23:21 - Ipratropium Bromide Trials and Patient Selection
26:52 - Combining Ablation With Sinus Surgery
31:13 - Where to Treat and Adding the Swell Body
34:47 - Sphenopalatine Artery Risk and Staggered Treatment
37:34 - Coding and Reimbursement
42:21 - Temperature Control Versus Impedance Control
47:13 - Cryoablation, Device Design and Closing Thoughts
---
More about this episode
The conversation follows the posterior nasal nerve from anatomy to the operating room. Dr. Davis describes a nerve that turned out to be a branching network rather than a single trunk, the early research on type 2 cytokine and sensory receptor changes in nasal secretions after ablation, and why he now thinks of the procedure as possible immune modulation rather than simply closing a tap. He then gets practical: the symptom scores he treats as nasal vital signs, the ipratropium bromide trial and what failing it really means, treating at the start of a sinus case while the field is dry, the staggered technique he credits for keeping delayed posterior bleeds rare, and the coding detail that makes combining the procedures viable. The episode closes on temperature control against impedance control, why he left cryoablation behind, and whether this nerve could one day keep patients off biologics.
---
Resources
Lanza DC, Kennedy DW. Adult rhinosinusitis defined. Otolaryngol Head Neck Surg. 1997
https://pubmed.ncbi.nlm.nih.gov/9334782/
BIOKLEAR, Effect of Temperature-Controlled Radiofrequency Ablation of the Posterior Nasal Nerve on Inflammatory Biomarkers in Patients With Allergic and Nonallergic Chronic Rhinitis (NCT06599736)
https://clinicaltrials.gov/study/NCT06599736
Allen DZ, et al. The Effect of Radiofrequency Ablation of Posterior Nasal Nerves on Inflammatory Cytokines, Peak Nasal Inspiratory Flow, and Subjective Symptom Scores in Chronic Rhinitis: A Prospective Clinical Trial. Ann Otol Rhinol Laryngol. 2026
https://doi.org/10.1177/00034894261449672
Stolovitzky JP, et al. 3-Year Outcomes of Temperature-Controlled Radiofrequency Ablation of the Posterior Nasal Nerve in Patients With Chronic Rhinitis. Int Forum Allergy Rhinol. 2025
https://doi.org/10.1002/alr.23577
Jamileh E, et al. Radiofrequency Neurolysis of the Posterior Nasal Nerve: A Systematic Review and Meta-Analysis. Laryngoscope. 2026
https://doi.org/10.1002/lary.70763
Kang YJ, et al. Comparative Effectiveness of Cryotherapy and Radiofrequency Ablation for Chronic Rhinitis: A Systematic Review and Meta-analysis. Clin Exp Otorhinolaryngol. 2023
https://doi.org/10.21053/ceo.2023.01214
Hopkins C, et al. Psychometric validity of the 22-item Sinonasal Outcome Test. Clin Otolaryngol. 2009
https://doi.org/10.1111/j.1749-4486.2009.01995.x
ExcelENT of Alabama, Dr. Chris Davis's practice
https://www.excelental.com
Dr. Ashley Agan, BackTable ENT contributor page
https://backtable.com/shows/ent/contributors/dr-ashley-agan
---
BackTable ENT & Allergy is the go-to podcast for otolaryngologists, allergists, and head and neck surgeons.
Download the free BackTable app to get early access to new episodes, cases, and courses curated by physicians in your specialty.
► https://www.backtable.com/app
When a child's cancer treatment threatens a child’s ability to speak, eat, or breath, how does a team decide what to address first? On this episode of BackTable ENT, host Dr. Gopi Shah welcomes Dr. Anthony Sheyn, pediatric otolaryngologist at Le Bonheur Children’s Hospital and St. Jude, and Amber Bonner, MS, CCC-SLP, acute care speech-language pathologist at Le Bonheur, to explore how a multidisciplinary team navigates the most challenging functional decisions in pediatric head and neck oncology.
---
Get the BackTable app
https://www.backtable.com/app
---
Timestamps
00:00 - Introduction
03:26 - Treatment Effects vs Tumor Effects
06:30 - Swallow and Airway Evaluation Timing
10:09 - Voice Assessment Protocols
13:13 - Feeding Decisions and Vocal Fold Immobility
17:23 - Vocal Fold Injection and Reinnervation
21:36 - Tracheostomy Timing and Family Teaching
26:08 - Complications and Swallowing Outcomes
29:48 - FEES Collaboration and Voice Prognosis
34:15 - Decannulation and Functional Outcomes
37:40 - Closing Remarks
---
More about this episode
They discuss baseline preoperative evaluation, strategies to distinguish tumor effects from treatment complications, and the pivotal role of instrumental swallow studies. The discussion covers standardized voice assessments, decisions around feeding tubes and tracheostomy, early vocal fold interventions, and the realities of family education and post-op rehab. Through real-world examples and collaborative protocols, Dr. Sheyn and Amber Bonner share how teams can set children up for meaningful recovery and long-term survivorship, bringing hope to families facing the toughest cases.
---
Resources
Nagy P, Beckmann N, Cox S, Sheyn A. Management of Vocal Fold Paralysis and Dysphagia for Neurologic Malignancies in Children. Ann Otol Rhinol Laryngol. 2019 https://pubmed.ncbi.nlm.nih.gov/31215235/
ASHA Practice Portal: Flexible Endoscopic Evaluation of Swallowing (FEES)
https://www.asha.org/practice-portal/resources/flexible-endoscopic-evaluation-of-swallowing/
ASHA Practice Portal: Videofluoroscopic Swallow Study (VFSS / modified barium swallow)
https://www.asha.org/practice-portal/resources/videofluoroscopic-swallow-study/
Zur KB et al. Pediatric Voice Handicap Index (pVHI): a new tool for evaluating pediatric dysphonia. Int J Pediatr Otorhinolaryngol. 2007
https://pubmed.ncbi.nlm.nih.gov/17046072/
Pediatric Auditory-Perceptual Evaluation of Voice, Part 2: A Protocol. J Speech Lang Hear Res. 2026
https://pubmed.ncbi.nlm.nih.gov/42600142/
Care of Infants and Children with Tracheostomies: An Official American Thoracic Society Clinical Practice Guideline
https://pmc.ncbi.nlm.nih.gov/articles/PMC12618984/
---
BackTable ENT & Allergy is the go-to podcast for otolaryngologists, allergists, and head and neck surgeons.
Download the free BackTable app to get early access to new episodes, cases, and courses curated by physicians in your specialty.
► https://www.backtable.com/app
Behind every complex pediatric cancer patient is a care team, and advanced practice providers are the key to keeping every moving piece connected. On this episode of BackTable ENT & Allergy, host Dr. Sara Helmig welcomes St. Jude APPs Sara Meehan (pediatric solid tumor oncology nurse practitioner) and Megan Murphy (ENT family nurse practitioner) to discuss the critical role APPs play across the full continuum of care. They walk through clinical responsibilities from pre-op to follow-up, the logistics of organizing multidisciplinary tumor boards, and the importance of care coordination across surgery, oncology, endocrinology, rehab, nutrition, and beyond.
---
Get the BackTable app
https://www.backtable.com/app
---
Timestamps
00:00 - Introduction
03:00 - APP Roles in Pediatric Oncology
08:01 - Epic and Workflow Tools
11:03 - Family Education and AI Support
17:26 - Expanding the APP Scope
22:08 - Telehealth and Remote Care
24:47 - Vision for Program Growth
27:31 - Closing Remarks
---
More about this episode
The conversation highlights the use of Epic tools and Abridge for documentation, patient education, and tumor board preparation, as well as the APP-family relationship, expectation setting, and early side effect management. Meehan and Murphy share opportunities for expanded APP scope, discuss telehealth and program growth, and reflect on challenges like cross-site communication and intake for out-of-state and international patients. The episode closes with insights on building well-rounded, family-centered care and strategies to strengthen the APP team’s impact.
---
BackTable ENT & Allergy is the go-to podcast for otolaryngologists, allergists, and head and neck surgeons.
Download the free BackTable app to get early access to new episodes, cases, and courses curated by physicians in your specialty.
► https://www.backtable.com/app
Treating pediatric head and neck cancer means thinking far beyond the initial diagnosis to ensure healthy growth, function, and future quality of life. For Pediatric Cancer Awareness Month, BackTable ENT & Allergy spotlights the unique challenges and innovations in caring for children with head and neck cancer. Host Dr. Gopi Shah is joined by Dr. Anthony Sheyn, leader of the head and neck cancer program at St. Jude Children’s Research Hospital, and Dr. Sara Helmig, pediatric oncologist at St. Jude, to discuss how multidisciplinary teams, advanced diagnostics, and family-centered care are reshaping outcomes for young patients.
---
Get the BackTable app
https://www.backtable.com/app
---
Timestamps
00:00 - Introduction
03:39 - Building a Multidisciplinary Program
06:54 - Patient Workup and Tumor Board Workflow
10:36 - Unique Considerations in Pediatric Head and Neck Cancer
13:31 - Recent Advances in Diagnosis and Treatment
16:42 - Balancing Margins, Function, and Protocols
19:56 - Managing Treatment Side Effects
23:35 - Endocrine and Craniofacial Development
27:30 - Fertility, Second Cancers, and Survivorship
32:45 - Looking Ahead: Program Innovations
36:23 - Closing Remarks
---
More about this episode
The episode explores how pediatric head and neck cancers differ from adult disease, including the critical role of molecular and genomic profiling, targeted therapies, proton radiation, and 3D surgical planning. Drs. Sheyn and Helmig describe the development of a comprehensive care program involving ENT, oncology, endocrinology, genetics, nutrition, dental, speech, and psychology specialists. They discuss strategies for balancing surgical margins with preservation of function, monitoring for treatment toxicity, and supporting endocrine and craniofacial development. Additional topics include fertility preservation, survivorship clinic models, long-term monitoring for secondary malignancies, and the use of AI to streamline tumor board workflows. The episode closes with a look at the future of pediatric head and neck oncology, including efforts to standardize protocols and enhance multidisciplinary collaboration.
---
Resources
Episode on Pediatric Thyroid Nodules
https://www.backtable.com/shows/ent/podcasts/274/pediatric-thyroid-nodules-clinical-insights-approaches
Episode on Molecular Diagnostics for Thyroid Nodules
https://www.backtable.com/shows/ent/podcasts/277/molecular-diagnostics-for-thyroid-nodules
---
BackTable ENT & Allergy is the go-to podcast for otolaryngologists, allergists, and head and neck surgeons.
Download the free BackTable app to get early access to new episodes, cases, and courses curated by physicians in your specialty.
► https://www.backtable.com/app
How is the “arms race” for research and academic credentials reshaping the ENT workforce and residency process? On this episode of BackTable ENT & Allergy, Dr. Ashley Agan sits down with Dr. Al Merati and Dr. Mark Whipple from the University of Washington to discuss the pressures ENT residency applicants face, the impact on specialty equity and rural access, and the challenges programs encounter in selecting the next generation of otolaryngologists. They explore survey data showing up to two-thirds of applicants feel compelled to present an “academic” persona, and why this trend may erode unity, transparency, and opportunities across the field.
---
Get the BackTable app
https://www.backtable.com/app
---
Timestamps
00:00 - Introduction
04:07 - Masking and Authentic Career Goals
07:16 - Preview: Crucial Conversations Panel
10:39 - Program Signaling and Application Volume
13:56 - Addressing the Rural Access Crisis
16:59 - Academic Drift and Fellowship Trends
19:33 - Accountability in Graduate Medical Education
25:22 - Defining Equity in the Application Process
29:12 - What Program Directors Want
33:58 - Prioritizing Impact Over Research Quantity
38:14 - Measuring Workforce Accountability
45:40 - Key Takeaways and Closing Remarks
---
More about this episode
The conversation covers the shifting importance of research productivity, changes in Step 1 and grading, program signaling, and how rural access gaps and a growing preference for academic careers are shaping the field. Drs. Merati and Whipple discuss the need for more exposure to comprehensive and community ENT, greater program transparency, and moving away from a publication-counting culture toward impact and accountability. They close with proposed solutions for residency programs, including normalizing all career paths, increasing equity, and rebalancing incentives to better serve both trainees and patients.
---
Resources
Crucial Conversations Panel – Sunday, October 18, 8:00 AM
AAOHNS schedule
---
BackTable ENT & Allergy is the go-to podcast for otolaryngologists, allergists, and head and neck surgeons.
Download the free BackTable app to get early access to new episodes, cases, and courses curated by physicians in your specialty.
► https://www.backtable.com/app
Which patients with obstructive sleep apnea are candidates for a GLP-1, and how do you start, escalate, and monitor one safely? On this episode of BackTable ENT & Allergy, host Dr. Gopi Shah is joined by obesity medicine specialist Dr. Shanail Berry and sleep specialist Dr. John Carter to discuss the practical questions that arise when adding GLP-1 and GLP/GIP therapies in OSA management. They discuss drug mechanisms and formulations, patient selection, screening and referral, management of side effects and contraindications, adherence strategies, perioperative considerations, and nutritional issues.
---
Get the BackTable app
https://www.backtable.com/app
---
Timestamps
00:00 - Introduction
02:18 - The Overlap Between Obesity and Sleep Apnea
04:02 - GLP-1 Medications: Basics and History
05:52 - Dual and Triple Agonists in Development
08:56 - Clinic Evaluation and Team-Based Referrals
14:18 - Navigating Insurance Coverage
17:28 - Key GLP-1 Trials in OSA
18:25 - Results from SURMOUNT-OSA
26:31 - Integrating CPAP and GLP-1 Therapy
37:35 - Moving Beyond AHI: New Assessment Metrics
40:40 - Safety, Perioperative Risks, and Sarcopenia
50:16 - Wrap-Up
---
More about this episode
The discussion also addresses the challenges of long-term GLP-1 therapy, including insurance barriers, prior authorizations, dose escalation, and common side effects. The doctors review when to reassess OSA after starting treatment, the growing importance of hypoxic burden beyond AHI, and strategies to prevent sarcopenia during weight loss. Throughout, they emphasize a multidisciplinary approach and the evolving landscape of OSA care in the era of GLP-1 therapies.
---
Resources
SCALE Study
https://pubmed.ncbi.nlm.nih.gov/26132939/
SURMOUNT-OSA Trial
https://pubmed.ncbi.nlm.nih.gov/38547961/
---
BackTable ENT & Allergy is the go-to podcast for otolaryngologists, allergists, and head and neck surgeons.
Download the free BackTable app to get early access to new episodes, cases, and courses curated by physicians in your specialty.
► https://www.backtable.com/app
With no FDA-approved therapies for Sjögren’s disease, how can ENTs and allergists provide effective care and keep up with emerging treatments? On this episode of BackTable ENT & Allergy, Dr. Basil Kahwash interviews Dr. Kara Wada, a Columbus-based allergist, immunologist, and lifestyle medicine physician, about her personal and clinical experience with Sjögren’s disease. They discuss the major gaps in current treatment, the evolving role of otolaryngologists and allergists in multidisciplinary care, and the new therapies on the horizon.
---
Get the BackTable app
https://www.backtable.com/app
---
Timestamps
00:00 - Introduction
02:21 - Building A Direct Practice
04:24 - Personal Sjogren's Diagnosis
08:33 - ENT Presentations
11:28 - Biopsy Challenges and Seronegative Disease
15:48 - Pulmonary Complications
17:55 - Clinical Trial Treatment
19:47 - Immunology and Disease Mechanisms
25:35 - Lab Workup and Risk Assessment
29:32 - Overlooked Symptoms and Nutritional Considerations
31:51 - Saliva Stimulants Tradeoffs
34:42 - Deciding When to Escalate Systemic Therapy
35:51 - Hydroxychloroquine Basics
38:26 - Multidisciplinary Dream Team
41:45 - Rituximab and IVIG
44:35 - Investigating Phase Three Therapies
47:23 - Path to Becoming a Sjogrens Expert
53:33 - Key Takeaways And Resources
---
More about this episode
Dr. Wada details her own diagnosis and the complex presentations of Sjögren’s across ENT subspecialties, including dry eyes, nasal and throat tissues, chronic sinus issues, laryngitis, reflux, salivary gland swelling, neuropathy, and dizziness. The conversation covers diagnostic workup, the importance of lip biopsy and expert pathology, the challenges of seronegative and pulmonary cases, and the limitations of current medications like hydroxychloroquine and rituximab. They also discuss ongoing clinical trials, dryness management, overlooked symptoms, and the emerging role of agents such as inalumab and dazedalimab in late-phase studies.
---
Resources
Virtual Sjögren’s Summit
https://www.sjogrenssummit.com/
---
BackTable ENT & Allergy is the go-to podcast for otolaryngologists, allergists, and head and neck surgeons.
Download the free BackTable app to get early access to new episodes, cases, and courses curated by physicians in your specialty.
► https://www.backtable.com/app
What if your pharmacist could help optimize a patient’s asthma treatment before their next clinic visit? On this episode of the BackTable ENT & Allergy Podcast, Dr. Basil Kahwash welcomes clinical pharmacist Dr. Joelle Ayoub to discuss how ambulatory care pharmacists can partner with ENT and allergy clinics to optimize asthma management. Dr. Ayoub shares her experience working in a family medicine clinic, collaborating with providers through referrals, reviewing medications, and providing direct patient education on inhaler use and disease management.
---
Get the BackTable app
https://www.backtable.com/app
---
Timestamps
00:00 - Introduction
02:40 - The Role of the Clinic Pharmacist
05:04 - Teaching Patients and Improving Inhaler Technique
12:36 - Choosing Inhalers and Applying Guidelines
18:51 - Comparing MDI, DPI, and SMI Devices
28:15 - Tracking Asthma Control and Monitoring Adherence
33:55 - Inhaler Education and Overcoming Barriers
40:00 - Using Social Media for Patient and Provider Education
44:16 - Pharmacist Collaboration and the Future of Team Care
50:58 - Answering Biologics Patient Questions
53:15 - SMART Therapy and Digital Inhaler Advances
55:19 - Wrap Up
---
More about this episode
They discuss common gaps in asthma care, with a focus on inhaler technique and medication adherence. Dr. Ayoub explains how device complexity, cost, and a patient’s ability to use their inhaler can all affect treatment. She also reviews the major inhaler types, common technique errors, and what to consider when choosing the right device for each patient. With this, Dr. Ayoub shares practical approaches to adherence monitoring, asthma guideline updates, and biologic monitoring. Throughout, Dr. Ayoub emphasizes the benefits of multidisciplinary collaboration and how pharmacists can help bridge gaps in care for patients with asthma.
---
Resources
Joelle Ayoub, PharmD, BCACP, APh - https://www.westernu.edu/bios/?bio=jayoub
---
BackTable ENT & Allergy is the go-to podcast for otolaryngologists, allergists, and head and neck surgeons.
Download the free BackTable app to get early access to new episodes, cases, and courses curated by physicians in your specialty.
► https://www.backtable.com/app
Aspirin or biologics? How do you choose the right treatment for AERD? On this episode of the BackTable ENT & Allergy Podcast, Dr. Basil Kahwash interviews Dr. Andrew White, Director of the AERD Clinic at Scripps Clinic, to discuss the diagnosis and management of this often underrecognized condition. They cover practical strategies for identifying AERD, the importance of a detailed NSAID history, and how treatment decisions are shaped by patient goals and disease severity.
---
Get the BackTable app
https://www.backtable.com/app
---
Timestamps
00:00 - Introduction
02:08 - What Is AERD and Prevalence
06:32 - History Taking and Mechanism
11:10 - Typical Symptom Progression and Alcohol Intolerance
16:41 - When to Do Aspirin Challenge
19:00 - Challenge Protocol And Upper Airway Reactions
24:53 - Aspirin Desensitization vs Challenge
27:58 - Aspirin therapy after desensitization and Risk of GI Bleeds
31:17 - Biologics Change AERD
33:42 - Choosing Aspirin Desensitization vs Biologics
35:52 - Patient Counseling and Motivational Interviewing
41:26 - Convenience and Cost of Therapy
44:10 - ENT Allergy Collaboration
47:22 - Rapid Fire Pearls
51:13 - Future Research & Management Direction
54:05 - Final Takeaways
---
More about this episode
Dr. White explains that AERD affects about 8 to 10 percent of asthmatics, with even higher rates in those with severe asthma or nasal polyps. He reviews typical adult-onset progression, alcohol-related respiratory symptoms, and the underlying pathophysiology, including imbalances in arachidonic acid mediators and leukotriene surges after NSAID exposure.
The conversation includes practical questions to ask when taking an NSAID history, such as reactions to common pain relievers or alcohol, and when to consider aspirin challenge. Dr. White also details long-term treatment strategies, including the role of biologics like dupilumab and aspirin therapy after desensitization, with considerations for dosing and gastrointestinal risk. He explains how factors like asthma severity, recurrent polyp disease, sense of smell, cost, and convenience all influence therapy choice. The episode concludes with a discussion of multidisciplinary collaboration, patient counseling, and Dr. White’s insights on future research directions in AERD management.
---
Resources
Aspirin sensitivity and severity of asthma: evidence for irreversible airway obstruction in patients with severe or difficult-to-treat asthma
https://pubmed.ncbi.nlm.nih.gov/16275362/
Polyphenolic Activation of Basophils Explains Alcohol Hypersensitivity in AERD
https://pubmed.ncbi.nlm.nih.gov/41065188/
New insights into the mechanisms of aspirin-exacerbated respiratory disease
https://pubmed.ncbi.nlm.nih.gov/39641750/
The role of aspirin desensitization followed by oral aspirin therapy in managing patients with aspirin-exacerbated respiratory disease: A Work Group Report from the Rhinitis, Rhinosinusitis and Ocular Allergy Committee of the American Academy of Allergy, Asthma & Immunology
https://pmc.ncbi.nlm.nih.gov/articles/PMC7980229/
Safety and outcomes of aspirin desensitization for aspirin-exacerbated respiratory disease: A single-center study
https://pubmed.ncbi.nlm.nih.gov/28550988/
Selection of aspirin dosages for aspirin desensitization treatment in patients with aspirin-exacerbated respiratory disease
https://pubmed.ncbi.nlm.nih.gov/17208597/
Factors influencing aspirin therapy after desensitization (ATAD) tolerance in aspirin-exacerbated respiratory disease (AERD) patients
https://pubmed.ncbi.nlm.nih.gov/41022281/
Feed the Good Wolf: Motivational Interviewing, Cognitive Behavioral Therapy, and Mindset
https://pubmed.ncbi.nlm.nih.gov/42103433/
---
BackTable ENT & Allergy is the go-to podcast for otolaryngologists, allergists, and head and neck surgeons.
Download the free BackTable app to get early access to new episodes, cases, and courses curated by physicians in your specialty.
► https://www.backtable.com/app
Can viewing the airway as one connected system change the future of respiratory care and improve patient outcomes? On this episode of the BackTable ENT & Allergy Podcast, Dr. Cedric Jamie Rutland, pulmonary and critical care medicine physician, joins Dr. Basil Kahwash to discuss the unified airway hypothesis and its implications for clinical care. They explore how upper and lower airway inflammation are closely linked, and why multidisciplinary collaboration is essential for treating the whole patient.
---
Get the BackTable app
https://www.backtable.com/app
---
Timestamps
00:00 - Introduction
05:06 - Understanding the Unified Airway
14:27 - Decoding Asthma Biomarkers
20:34 - Endotyping in Clinical Practice
26:36 - Addressing Asthma Symptom and “Outgrowing” Asthma
32:13 - Strategies for Precision Biologics
34:23 - Navigating Insurance and Treatment Indications
35:36 - Treating the Whole Patient and Breaking Down Specialty Silos
46:07 - Effective Patient Communication
51:36 - Asthma Lightning Round
57:33 - Biologics and Airway Remodeling
1:00:00 - Closing Thoughts
---
More about this episode
The conversation covers the biology of type II inflammation, the use of biomarkers and biologics for more personalized treatment, and practical strategies for overcoming insurance barriers and specialty silos. Dr. Rutland shares insights on patient communication, the limitations of current diagnostics, and the impact of chronic inflammation on systemic disease. The episode highlights the need for ENT, allergy, and pulmonology teams to work together and embrace a connected view of airway disease to achieve better patient outcomes.
---
Resources
Dr. Jamie Rutland -
https://www.lung.org/media/meet-our-experts/cedric-jamie-rutland-md
---
BackTable ENT & Allergy is the go-to podcast for otolaryngologists, allergists, and head and neck surgeons.
Download the free BackTable app to get early access to new episodes, cases, and courses curated by physicians in your specialty.
► https://www.backtable.com/app
From the publisher's feed

31,898 Listeners

14,272 Listeners

18 Listeners

21 Listeners

87,110 Listeners

2,440 Listeners

111,814 Listeners

6 Listeners

9,155 Listeners

6,070 Listeners

29,171 Listeners

15,886 Listeners

2,513 Listeners

11,384 Listeners

1,620 Listeners